Product Information
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Strides Pharma Inc., priced at $0.1561 per EA under NDC 64380072106. Its NADAC has been published 582 times since Dec 17, 2014.
Strength
1 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380072106
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090687On Market Since
8/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has been published 582 times since Dec 17, 2014, and over the history we have for it it has declined 86.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1561 per EA |
|---|---|
| All-time high | $1.1537 (Jan 14, 2015) |
| All-time low | $0.1561 (Jun 17, 2026) |
| 52-week high | $0.1769 |
| 52-week low | $0.1561 |
| Median price | $0.2819 |
| Average price | $0.3722 |
| Largest weekly change | +114.2% (Oct 23, 2019) |
| Weeks tracked | 582 |
| Tracking since | Dec 17, 2014 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Strides Pharma Inc., is $0.1561 per EA (NDC 64380072106), effective Jun 24, 2026.
How has the price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has declined 86.5%. It has been tracked across 582 weekly CMS publications since Dec 17, 2014.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Since Dec 17, 2014, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1561 (Jun 17, 2026) to a high of $1.1537 (Jan 14, 2015), with a median of $0.2819 per EA.
Are there cheaper alternatives to TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
13 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) (NDC 64380072106) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification